Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novo Nordisk A/S
Senhwa Biosciences, Inc.
PCI Biotech AS
Federation Francophone de Cancerologie Digestive
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University College, London
NYU Langone Health